Systematic pan-cancer analysis reveals context-dependent prognostic and immunological roles of WDR1 with divergent effects in renal and gastric cancers - Report - MDSpire
Advertisement
Systematic pan-cancer analysis reveals context-dependent prognostic and immunological roles of WDR1 with divergent effects in renal and gastric cancers
Clinical Report: Comprehensive Pan-Cancer Evaluation of WDR1
Overview
This study evaluates the expression patterns, prognostic significance, and immune associations of WDR1 across various cancers.
Background
WDR1 is a key regulator of actin dynamics, which is crucial for tumor cell proliferation and migration. Understanding its role in cancer is important for exploring context-specific factors influencing tumor behavior and treatment responses.
Data Highlights
No numerical data or trial data presented in the article.
Key Findings
WDR1 expression varies significantly across different cancer types.
WDR1 is positively correlated with immune cell infiltration and immune checkpoint molecules.
Functional analyses reveal WDR1-related genes are involved in actin cytoskeleton organization.
WDR1 expression correlates with differential responses to various therapeutic agents.
Experimental validation shows WDR1 has opposing effects in renal versus gastric cancer cells.
Clinical Implications
WDR1 may serve as a potential biomarker for cancer prognosis and treatment response. Its context-dependent effects in different tumor types highlight the need for personalized approaches in cancer therapy.
Conclusion
WDR1 is implicated in tumor progression and immune microenvironment remodeling, warranting further investigation as a biomarker in cancer.
